期刊文献+

当归药用价值与上市药品研究进展 被引量:13

Research progress on medicinal value and marketed drugs of Angelicae Sinensis Radix
原文传递
导出
摘要 当归Angelica Sinensis Radix为“血之圣药”,其补血活血、调经止痛功效显著。当归含有挥发油、酚酸类、多糖、黄酮等成分,对人体的造血、循环、神经、免疫等具有较强的药理作用。以当归或其主要活性成分为原料的药品种类繁多,剂型丰富,功效多样,应用广泛,有巨大的开发潜力。通过对当归及其药品在临床应用、质量标准等方面的最新进展进行综述,为当归在临床医学中的广泛应用提供理论和技术支持,为当归药材的进一步开发利用提供参考。 Danggui(Angelicae Sinensis Radix)is known as the“holy medicine of blood”,mainly known for its effects of tonifying blood,promoting blood circulation,regulating menstruation and relieving pain.Angelicae Sinensis Radix contains volatile oil,phenolic acids,polysaccharides,flavonoids and other components,and has strong pharmacological effects on hematopoietic,circulatory,nervous and immune systems of human body.There are many kinds of drugs using Angelicae Sinensis Radix or its main active ingredients as raw materials,with rich dosage forms,diverse effects,wide application,and great development potential.This study systematically reviewed the latest progress of Angelicae Sinensis Radix and its derivative drugs in clinical application and quality standards,so as to provide theoretical and technical support for the wider application of Angelicae Sinensis Radix in clinical medicine,and provide reference for the further development and utilization of Angelicae Sinensis Radix.
作者 李欣怡 向超群 陈启文 赖嘉敏 蔡思燕 王乐琪 李莎莎 严诗楷 肖雪 LI Xinyi;XIANG Chaoqun;CHEN Qiwen;LAI Jiamin;CAI Siyan;WANG Leqi;LI Shasha;YAN Shikai;XIAO Xue(Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine(Institute of Traditional Chinese Medicine),Guangdong Pharmaceutical University,Guangzhou 510006,China;The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;School of Pharmacy,Shanghai Jiaotong University,Shanghai 200240,China)
出处 《中草药》 北大核心 2025年第3期1037-1049,共13页 Chinese Traditional and Herbal Drugs
基金 广东省中医药局中医药科研项目(科研平台专项)(20224046) 中国仪器仪表学会科学仪器托举计划项目(CISTJ2024) 国家药品监督管理局药品快速检验技术重点实验室开放课题(KF2022002,KF2022006)。
关键词 当归 阿魏酸 上市药品 临床应用 综合开发 Angelicae Sinensis Radix ferulic acid marketed drugs clinical application comprehensive development
  • 相关文献

参考文献104

二级参考文献892

共引文献1838

同被引文献297

引证文献13

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部